@article{90c7d982fc534e19a7c411d8bb117822,
title = "Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review",
keywords = "Anticoagulation, direct oral anticoagulants, non-valvular atrial fibrillation, real-world evidence, stroke prevention, Rivaroxaban, Pyrazoles, Humans, Pyridones, Dabigatran, Atrial Fibrillation, Vitamin K/antagonists & inhibitors",
author = "Steve Deitelzweig and Lip, {Gregory Y H}",
year = "2019",
month = jun,
doi = "10.1080/14737167.2019.1592834",
language = "English",
volume = "19",
pages = "243–244",
journal = "Expert Review of Pharmacoeconomics & Outcomes Research",
issn = "1473-7167",
publisher = "Taylor & Francis",
number = "3",
}